Cortisol 21-sulfate
CAS 1253-43-6 MFCD01253436
化学结构图
SMILES: C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@]2(O)C(=O)COS(=O)(=O)O
化学属性
| Mol. Weight | 442.52 |
|---|---|
| Mol. Formula | C21H30O8S |
别名和识别编码
| CAS Number | 1253-43-6 |
|---|---|
| Chemical Name | Cortisol 21-sulfate |
| Synonym | ######## 11,17-dihydroxy-4-pregnene-3,20-dione-21-yl-sulfate 4-pregnen-11,17,21-triol-3,20-dione 21-sulfate F(K)S cpd SS441 compound cortisol 21-sulfate cortisol 21-sulfate, 1,2-T2-labeled cortisol 21-sulfate, 4-(14)C-labeled cortisol sulfate cortisol-21-sulfate |
| InChIKey | JOVLCJDINAUYJW-VWUMJDOOSA-N |
| PubChem Substance ID | 102172 |
| InChI | InChI=1S/C21H30O8S/c1-19-7-5-13(22)9-12(19)3-4-14-15-6-8-21(25,17(24)11-29-30(26,27)28)20(15,2)10-16(23)18(14)19/h9,14-16,18,23,25H,3-8,10-11H2,1-2H3,(H,26,27,28)/t14-,15-,16-,18+,19-,20-,21-/m0/s1 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- Metabolites & Impurities
- Pharmaceuticals
- Intermediates & Fine Chemicals
- Steroids
产品应用
- Cortisol 21-Sulfate is a phase II metabolite of Cortisol (H714615).
相关文献及参考
- [2]. S S Singer, et al. Enzymatic sulfation of steroids: I. The enzymatic basis for the sex difference in cortisol sulfation by rat liver preparations. Endocrinology. 1976 Apr;98(4):963-74.
- [3]. T Hayashi, et al. Cortisol-21-sulfate (FS) is a specific ligand for intracellular transcortin: demonstration of three types of high affinity corticosteroid binders in bovine aortic cytosol by a combined use of FS and RU 28362. Endocrinology. 1990 Jan;126(1):307-16.
- [4]. S Miyabo, et al. Behavioral and other systemic effects of cortisol-21 sulfate. Horm Behav. 1972 Sep;3(3):227-36.
- Choi, M., et al.: Steroids, 65, 54 (2000),
- Spielgelhalder, B., et al.: J. Steroid Biochem., 7, 749 (1976),
- Vanluchene, E., et al.: J. Chromatogr., 456, 175 (1988),
- [1]. C S Hall, et al. Simultaneous metabo
- [1]. C S Hall, et al. Simultaneous metabolism of cortisol sulfate and cortisol in normal human adults. J Clin Endocrinol Metab. 1970 Oct;31(4):439-44.
